HALEON PLC (H6D0.DE) Fundamental Analysis & Valuation

FRA:H6D0 • GB00BMX86B70

Current stock price

4.063 EUR
-0.05 (-1.12%)
Last:

This H6D0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. H6D0.DE Profitability Analysis

1.1 Basic Checks

  • H6D0 had positive earnings in the past year.
  • H6D0 had a positive operating cash flow in the past year.
  • Each year in the past 5 years H6D0 has been profitable.
  • Each year in the past 5 years H6D0 had a positive operating cash flow.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • H6D0 has a Return On Assets (5.11%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 10.15%, H6D0 is in line with its industry, outperforming 53.06% of the companies in the same industry.
  • H6D0 has a Return On Invested Capital of 7.04%. This is comparable to the rest of the industry: H6D0 outperforms 48.98% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for H6D0 is significantly below the industry average of 14.21%.
  • The last Return On Invested Capital (7.04%) for H6D0 is above the 3 year average (6.87%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 7.04%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 15.11%, H6D0 is doing good in the industry, outperforming 65.31% of the companies in the same industry.
  • In the last couple of years the Profit Margin of H6D0 has grown nicely.
  • The Operating Margin of H6D0 (22.78%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of H6D0 has remained more or less at the same level.
  • H6D0 has a worse Gross Margin (65.01%) than 63.27% of its industry peers.
  • In the last couple of years the Gross Margin of H6D0 has remained more or less at the same level.
Industry RankSector Rank
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. H6D0.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so H6D0 is destroying value.
  • H6D0 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, H6D0 has less shares outstanding
  • Compared to 1 year ago, H6D0 has an improved debt to assets ratio.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • H6D0 has an Altman-Z score of 2.44. This is not the best score and indicates that H6D0 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • H6D0 has a Altman-Z score of 2.44. This is comparable to the rest of the industry: H6D0 outperforms 44.90% of its industry peers.
  • The Debt to FCF ratio of H6D0 is 3.87, which is a good value as it means it would take H6D0, 3.87 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 3.87, H6D0 perfoms like the industry average, outperforming 59.18% of the companies in the same industry.
  • H6D0 has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.47, H6D0 is in line with its industry, outperforming 59.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Altman-Z 2.44
ROIC/WACC0.84
WACC8.37%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • H6D0 has a Current Ratio of 0.92. This is a bad value and indicates that H6D0 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.92, H6D0 is doing worse than 77.55% of the companies in the same industry.
  • A Quick Ratio of 0.71 indicates that H6D0 may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.71, H6D0 is doing worse than 75.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. H6D0.DE Growth Analysis

3.1 Past

  • H6D0 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
  • The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
  • Looking at the last year, H6D0 shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
  • H6D0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • H6D0 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.99% yearly.
  • Based on estimates for the next years, H6D0 will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.99%
Revenue Next Year-1.37%
Revenue Next 2Y0.84%
Revenue Next 3Y2.02%
Revenue Next 5Y3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.05 0.1 0.15 0.2 0.25

More info and screens

Find the best growth stocksShow best growing peers

3

4. H6D0.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.35, the valuation of H6D0 can be described as rather expensive.
  • H6D0's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of H6D0 to the average of the S&P500 Index (26.91), we can say H6D0 is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 16.63, which indicates a correct valuation of H6D0.
  • H6D0's Price/Forward Earnings ratio is in line with the industry average.
  • H6D0's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 19.35
Fwd PE 16.63
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • H6D0's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of H6D0 indicates a somewhat cheap valuation: H6D0 is cheaper than 73.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.11
EV/EBITDA 13.44
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.06
PEG (5Y)1.1
EPS Next 2Y8.72%
EPS Next 3Y9.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. H6D0.DE Dividend Analysis

5.1 Amount

  • H6D0 has a Yearly Dividend Yield of 2.02%.
  • Compared to an average industry Dividend Yield of 1.96, H6D0 pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, H6D0 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.02 0.04 0.06

5.3 Sustainability

  • 36.71% of the earnings are spent on dividend by H6D0. This is a low number and sustainable payout ratio.
DP36.71%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
H6D0.DE Dividend Payout.H6D0.DE Dividend Payout, showing the Payout Ratio.H6D0.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

H6D0.DE Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC

FRA:H6D0 (4/27/2026, 7:00:00 PM)

4.063

-0.05 (-1.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.66%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap36.19B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target5.15 (26.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.02%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.1%
PT rev (3m)1.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.33%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE 19.35
Fwd PE 16.63
P/S 2.84
P/FCF 14.11
P/OCF 11.9
P/B 1.91
P/tB N/A
EV/EBITDA 13.44
EPS(TTM)0.21
EY5.17%
EPS(NY)0.24
Fwd EY6.01%
FCF(TTM)0.29
FCFY7.09%
OCF(TTM)0.34
OCFY8.41%
SpS1.43
BVpS2.13
TBVpS-1.19
PEG (NY)3.06
PEG (5Y)1.1
Graham Number3.17227 (-21.92%)
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 9.07%
ROIC 7.04%
ROICexc 7.4%
ROICexgc 256.74%
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
FCFM 20.14%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
ROICexc(3y)7.38%
ROICexc(5y)6.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.85%
ROCE(5y)8.36%
ROICexgc growth 3Y31.03%
ROICexgc growth 5Y32.63%
ROICexc growth 3Y5.68%
ROICexc growth 5Y5.43%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Debt/EBITDA 2.71
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 7.04
Cash Conversion 91.68%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.44
F-Score8
WACC8.37%
ROIC/WACC0.84
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.99%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y0.84%
Revenue Next 3Y2.02%
Revenue Next 5Y3%
EBIT growth 1Y-1.26%
EBIT growth 3Y1.06%
EBIT growth 5Y2.67%
EBIT Next Year21.48%
EBIT Next 3Y11.4%
EBIT Next 5Y8.96%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC / H6D0.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC?

ChartMill assigns a fundamental rating of 4 / 10 to H6D0.DE.


Can you provide the valuation status for HALEON PLC?

ChartMill assigns a valuation rating of 3 / 10 to HALEON PLC (H6D0.DE). This can be considered as Overvalued.


Can you provide the profitability details for HALEON PLC?

HALEON PLC (H6D0.DE) has a profitability rating of 5 / 10.


What is the valuation of HALEON PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HALEON PLC (H6D0.DE) is 19.35 and the Price/Book (PB) ratio is 1.91.


What is the financial health of HALEON PLC (H6D0.DE) stock?

The financial health rating of HALEON PLC (H6D0.DE) is 4 / 10.